[1]蔡迎彬,张玉俊,王岩,等.胃腺体组织癌变过程中CD44和survivin表达与幽门螺杆菌感染的相关性及其在胃癌浸润和转移中的作用[J].新乡医学院学报,2023,40(8):729-735.[doi:10.7683/xxyxyxb.2023.08.005]
　CAI Yingbin,ZHANG Yujun,WANG Yan,et al.Relationship between CD44,survivin expression and Helicobacter pylori infection in gastric gland tissue carcinogenesis and their role in infiltration and metastasis of gastric cancer[J].Journal of Xinxiang Medical University,2023,40(8):729-735.[doi:10.7683/xxyxyxb.2023.08.005]
点击复制

胃腺体组织癌变过程中CD44和survivin表达与幽门螺杆菌感染的相关性及其在胃癌浸润和转移中的作用
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年8
页码:
729-735
栏目:
临床研究
出版日期:
2023-08-05

文章信息/Info

Title:
Relationship between CD44,survivin expression and Helicobacter pylori infection in gastric gland tissue carcinogenesis and their role in infiltration and metastasis of gastric cancer
作者:
蔡迎彬1; 张玉俊2; 王岩1; 李可3
（1.新疆医科大学附属肿瘤医院内镜诊疗中心，新疆　乌鲁木齐　830054；2.新疆医科大学公共卫生学院，新疆　乌鲁木齐　830011；3.新疆医科大学第五附属医院消化内科，新疆　乌鲁木齐　830000）
Author(s):
CAI Yingbin1; ZHANG Yujun2; WANG Yan1; LI Ke3
（1.Endoscopic Diagnosis and Treatment Center,Cancer Hospital Affiliated to Xinjiang Medical University,Urumqi 830054,Xinjiang Uygur Autonomous Region,China；2.Public Health Institute of Xinjiang Medical University,Urumqi 830011,Xinjiang Uygur Autonomous Region,China;3.Department of Gastroenterology,the Fifth Affiliated Hospital of Xinjiang Medical University,Urumqi 830000,Xinjiang Uygur Autonomous Region,China）
关键词:
胃癌; 幽门螺杆菌; CD44; survivin
Keywords:
gastric cancer; Helicobacter pylori; CD44; survivin
分类号:
R735.2
DOI:
10.7683/xxyxyxb.2023.08.005
文献标志码:
A
摘要:
目的　分析胃腺体组织癌变过程中CD44、survivin表达与幽门螺杆菌（HP）感染的相关性，探讨CD44、survivin在胃腺体组织癌变过程及胃癌（GC）浸润和转移中的作用。
方法　选择2022年4月至2022年6月于新疆医科大学附属肿瘤医院就诊的资料完整且为首次经胃镜及病理学检查后确诊慢性非萎缩性胃炎（CNAG）患者（CNAG组）、慢性萎缩性胃炎（CAG）患者（CAG组）、肠上皮化生（IM）患者（IM组）、异型增生（AH）患者（AH组）和GC患者（GC组）各50例为研究对象，收集各组患者的胃黏膜病变组织。采用快速尿素酶和碳14法分别检测CNAG、CAG、IM、AH和GC患者胃黏膜病变组织中HP感染情况，苏木精-伊红染色观察不同患者胃黏膜病变组织形态，免疫组织化学法检测不同患者胃黏膜病变组织中CD44和survivin的蛋白表达水平，实时荧光定量聚合酶链反应检测不同患者胃黏膜病变组织中CD44和survivin mRNA表达。
结果　250例患者中， HP感染率为50.4%(126/250)，其中 CNAG、CAG、IM、AH和GC患者的HP感染率分别为10.0%（5/50）、24.0%(12/50)、44.0%(22/50)、68.0%(34/50)、80.0%(40/50)，HP感染率呈显著增高趋势（χ2=68.068，P<0.001）。CNAG组、CAG组、IM组、AH组和GC组患者胃黏膜病变组织中CD44蛋白阳性表达率分别为4.0%、16.0%、32.0%、62.0%、80.0%，呈逐渐升高趋势（χ2=84.50，P<0.001）。CAG组、IM组、AH组和GC组胃黏膜病变组织中survivin蛋白阳性表达率分别为18.0%、38.0%、58.0%、68.0%，呈逐渐升高趋势（χ2=67.63，P<0.001）。CAG组、IM组、AH组和GC组患者胃黏膜病变组织中CD44 和survivin mRNA 相对表达量显著高于CNAG组，IM组、AH组和GC组患者胃黏膜病变组织中CD44和survivin mRNA相对表达量显著高于CAG组，AH组和GC组患者胃黏膜病变组织中CD44和survivin mRNA相对表达量显著高于IM组，GC组患者胃黏膜病变组织中CD44和survivin mRNA相对表达量显著高于AH组（P<0.001）。CAG组、IM组、AH和GC组HP阳性患者胃黏膜组织中CD44、survivin蛋白阳性表达率显著高于阴性患者（P<0.01）。CNAG组HP阳性患者与阴性患者胃黏膜组织中CD44、survivin蛋白阳性表达率比较差异无统计学意义（P>0.05）。CD44和survivin蛋白表达与GC患者癌组织分化程度、淋巴结转移、远处转移相关（P<0.05）， CD44和survivin蛋白表达与GC患者的浸润深度无相关性（P>0.05）。
结论　HP感染与CD44和survivin基因表达间存在正关联，胃腺体组织癌变过程中Hp 感染可能诱导CD44和 survivin 基因表达，从而通过改变黏膜细胞的生物学活性来发挥促癌作用；CD44和survivin可促进GC的浸润和转移。
Abstract:
Objective　To analyze the correlation between the expressions of CD44 and survivin and Helicobacter pylori (HP) infection during the carcinogenesis process of gastric gland tissue,and explore the role of CD44 and survivin in the carcinogenesis process of gastric gland tissue and infiltration and metastasis of gastric cancer (GC).
Methods　The 50 cases of chronic non-atrophic gastritis (CNAG) patients (CNAG group),50 cases of chronic atrophic gastritis (CAG) patients (CAG group),50 cases of intestinal metaplasia (IM) patients (IM group),50 cases of atypical hyperplasin (AH) patients (AH group) and 50 GC patients (GC group) diagnosed by gastroscopy and pathology for the first time with complete data admitted to Cancer Hospital Affiliated to Xinjiang Medical University from April to June 2022 were selected as the rearch subieets,and the gastric mucosa lesions of the patients in each group were collected.The HP infection in gastric mucosa pathological tissues of CNAG,CAG,IM,AH and GC patients was detected by rapid urease and C-14 methods,respectively.The morphology of gastric mucosa lesions of different patients was observed by hematoxylin-eosin staining.The expressions of CD44 and survivin protein in gastric mucosa lesions of different patients were detected by immunohistochemical method.The expressions of CD44 and survivin mRNA in gastric mucosa lesions of different patients were detected by real-time fluorescence quantitative polymerase chain reaction.
Results　Among the 250 patients,the HP infection rate was 50.4% (126/250),and the HP infection rate of CNAG,CAG,IM,AH,and GC patients were 10.0% (5/50),24.0% (12/50),44.0% (22/50),68.0% (34/50),and 80.0% (40/50),respectively;the HP infection rate showed a significant increase trend (χ2=68.068,P<0.001).The positive expression rates of CD44 protein in gastric mucosa lesions of patients in the CNAG group,CAG group,IM group,AH group and GC group were 4.0%,16.0%,32.0%,62.0% and 80.0%,respectively,which showed a gradually increasing trend (χ2=84.500,P<0.001).The positive expression rates of survivin protein in gastric mucosa lesions of patients in the CAG group,IM group,AH group and GC group were 18.0%,38.0%,58.0% and 68.0%,respectively,which showed a gradually increasing trend (χ2=67.630,P<0.001).The relative expression levels of CD44 and survivin mRNA in gastric mucosa lesions of patients in the CAG group,IM group,AH group and GC group were significantly higher than those in the CNAG group (P<0.001);the relative expression levels of CD44 and survivin mRNA in gastric mucosa lesions of patients in the IM group,AH group and GC group were significantly higher than those in the CAG group (P<0.001);the relative expression levels of CD44 and survivin mRNA in gastric mucosa lesions of patients in the AH group and GC group were significantly higher than those in the IM group (P<0.001);the relative expression levels of CD44 and survivin mRNA in gastric mucosa lesions of patients in the GC group were significantly higher than those in the AH group (P<0.001).The positive expression rates of CD44 and survivin protein in gastric mucosa of HP positive patients was significantly higher than those of HP negative patients in the CAG group,IM group,AH group and GC group (P<0.01).There was no significant difference in the positive expression rates of CD44 and survivin protein in gastric mucosa between HP positive patients and negative patients in the CNAG group (P>0.05).The expressions of CD44 and survivin was correlated with the degree of cancer tissue differentiation,lymph node metastasis and distant metastasis in GC patients (P<0.05);while the expressions of CD44 and survivin protein was not correlated with the depth of infiltration in GC patients (P>0.05).
Conclusion　There is a positive correlation between HP infection and the expression of CD44 and survivin gene.During the carcinogenesis process of gastric gland tissue,Hp infection may induce the expression of CD44 and survivin gene,thereby exerting a tumor-promoting effect by altering the biological activity of mucosal cells;CD44 and survivin can promote the infiltration and metastasis of GC.

参考文献/References:

［1］　XU M Q,SUN K,CAO C,et al.Age-related twin-peak prevalence profiles of H.pylori infection,gastritis,GIN and gastric cancer:analyses of 70,534 patients with gastroscopic biopsies［J］.PLoS One,2022,17(7):e0265885.
［2］　LIU C,NG S K,DING Y,et al.Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis［J］.Oncogene,2022,41(28):3599-3610.
［3］　VAHIDI S,MIRZAJANI E,NOROLLAHI S E,et al.Performance of DNA methylation on the molecular pathogenesis of Helicobacter pylori in gastric cancer;targeted therapy approach［J］.J Pharmacopuncture,2022,25(2):88-100.
［4］　PARK C H,LEE A R,LEE Y R,et al.Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing［J］.Helicobacter,2019,24(1):e12547.
［5］　GENG H,DONG Z,ZHANG L,et al.An immune signature for risk stratification and therapeutic prediction in Helicobacter pylori-infected gastric cancer［J］.Cancers (Basel),2022,14(13):3276.
［6］　NAGASAKI N,ITO M,BODA T,et al.Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings:a large-scale retrospective cohort study［J］.BMC Gastroenterol,2022,22(1):299.
［7］　XIE P,YAN J,WU M,et al.CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis［J］.Ann Transl Med,2022,10(12):689.
［8］　LUBANSKA D,ALRASHED S,MASON G T,et al.Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles［J］.Sci Rep,2022,12(1):12078.
［9］　WEICHERT W,DENKERT C,BURKHARDT M,et al.Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival［J］.Clin Cancer Res,2005,11(18):6574-6581.
［10］　VILLARD A V,GENNA A,LAMBERT J,et al.Regulation of tissue factor by CD44 supports coagulant activity in breast tumor cells［J］.Cancers (Basel),2022,14(13):3288.
［11］　SIHOMBING U H M,ANDRIJONO,PURWOTO G,et al.Expression of CD44+/CD24-,RAD6 and DDB2 on chemotherapy response in ovarian cancer:a prospective flow cytometry study［J］. Gynecol Oncol Rep,2022,42:101005.
［12］　SINGH A,SPITZER M H,JOY J P,et al.Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes［J］.Proc Natl Acad Sci U S A,2022,119(18):e2115567119.
［13］　JIA R,GUO X,LIU H,et al.Analysis of staged features of gastritis-cancer transformation and identification of potential biomarkers in gastric cancer［J］.J Inflamm Res,2022,15:6857-6868.
［14］　SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［15］　SANO T,COIT D G,KIM H H,et al.Proposal of a new stage grouping of gastric cancer for TNM classification:international gastric cancer association staging project［J］.Gastric Cancer,2017,20(2):217-225.
［16］　BALI P,COKER J,LOZANO-POPE I,et al.Microbiome signatures in a fast- and slow-progressing gastric cancer murine model and their contribution to gastric carcinogenesis［J］.Microorganisms,2021,9(1):189.
［17］　AHADI A.Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression［J］. IUBMB Life,2020,72(5):884-898.
［18］　ZHU X,SU T,WANG S,et al.New advances in nano-drug delivery systems:Helicobacter pylori and gastric cancer［J］.Front Oncol,2022,12:834934.
［19］　LIU X,SHAO L,LIU X,et al.Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer［J］.EBioMedicine,2019,40:336-348.
［20］　MOKHTARIAN R,TABATABAEIAN H,SAADATMAND P,et al.CD44 gene rs8193 C allele is significantly enriched in gastric cancer patients［J］.Cell J,2020,21(4):451-458.
［21］　SOHN S H,KIM B,SUL H J,et al.Foretinib inhibits cancer stemness and gastric cancer cell proliferation by decreasing CD44 and c-MET signaling［J］.Onco Targets Ther,2020,13:1027-1035.
［22］　ELAKAD O,HUPL B,LABITZKY V,et al.Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer［J］.NPJ Precis Oncol,2022,6(1):52.
［23］　GUO T,ZHU Y,YUE M,et al.The therapeutic effects of DDP/CD44-shRNA nanoliposomes in AMF on ovarian cancer［J］.Front Oncol,2022,12:811783.
［24］　GAO X,LU C,CHEN C,et al.ARPP-19 mediates herceptin resistance via regulation of CD44 in gastric cancer［J］.Onco Targets Ther,2020,13:6629-6643.
［25］　DMMRICH J,VOLLMERS H P,HEIDER K H,et al.Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading［J］.J Mol Med (Berl),1995,73(8):395-401.
［26］　PARK J Y,SEO H,KANG C S,et al.Dysbiotic change in gastric microbiome and its functional implication in gastric carcinogenesis［J］.Sci Rep,2022,12(1):4285.
［27］　LIU N,QI D,JIANG J,et al.Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer［J］.Oncol Lett,2022,23(6):193.
［28］　LIU X,ZHAO Y,ZHANG W,et al.Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis［J］.Onco Targets Ther,2018,11:3087-3100.
［29］　MIHANFAR A,YOUSEFI B,GHAZIZADEH DARBAND S,et al.Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP［J］.Bioimpacts,2021,11(4):253-261.
［30］　KIM W J,KIM W,BAE J M,et al.Dehydroabietic acid is a novel survivin inhibitor for gastric cancer［J］.Plants (Basel),2021,10(6):1047.
［31］　HASEGAWA T,SUGIHARA T,HOSHINO Y,et al.Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein survivin in a light-independent manner［J］.Oncol Lett,2021,22(4):703.

〖KH-2\*4〗
［32］　BURY J,SZUMIO J,D〖KG-\*4〗〖XCs.TIF;%80%80〗〖KG-\*9〗BROWSKI A,et al.Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma［J］.Pol Przegl Chir,2012,84(7):341-347.
［33］　GU Y,JIN S,WANG F,et al.Clinicopathological significance of PI3K,Akt and survivin expression in gastric cancer［J］.Biomed Pharmacother,2014,68(4):471-475.
［34］　MIYACHI K,FUJITA M,TANAKA N,et al.Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer［J］.J Exp Clin Cancer Res,2002,21(2):269-275.
［35］　TSUBURAYA A,NOGUCHI Y,YOSHIKAWA T,et al.An anti-apoptosis gene,survivin and telomerase expression in gastric cancer［J］.Hepatogastroenterology,2002,49(46):1150-1152.
［36］　HOU W,KONG L,HOU Z,et al.CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer［J］.BMC Med Genomics,2022,15(1):225.
［37］　XIE J W,CHEN P C,ZHENG C H,et al.Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer［J］.J Cancer Res Clin Oncol,2015,141(10):1809-1817.

相似文献/References:

[1]陈赜,陈杰,严想元,等.腹腔镜辅助胃癌根治术治疗早期胃癌疗效观察[J].新乡医学院学报,,():000.
[2]于成功,萧树东,赵宪邨,等.胃癌胃良性病变患者血清和局部组织中IL—I水平及意义[J].新乡医学院学报,1996,13(03):220.
[3]王淑秀,赵卫星,和瑞芝,等.P~(53)和rasP~(21)在胃癌中表达的免疫组化研究[J].新乡医学院学报,1997,14(02):137.
[4]赵卫星,王淑秀,卢朝晖,等.幽门螺杆菌与胃癌基因抑癌基因突变的关系[J].新乡医学院学报,1997,14(03):203.
[5]王淑秀.抑癌基因和癌基因与胃癌[J].新乡医学院学报,1997,14(01):083.
[6]冯艳玲,乐晓萍,蔡新华.胃癌患者P16和P53蛋白的表达及其相互关系[J].新乡医学院学报,2000,17(06):403.
[7]周玲生.纤维胃镜粘膜活检1356 例病理分析[J].新乡医学院学报,2000,17(06):462.
[8]任金萍,王淑秀,付华民,等.青年与老年人胃癌中PCNA和AgNOR计数表达的对比研究[J].新乡医学院学报,2000,17(03):156.
[9]窦天伟,刘 炯,罗志勇,等.复发胃癌再次手术42例疗效和随访结果[J].新乡医学院学报,2003,20(05):337.
[10]张德志,王全志,张永辉.增殖细胞核抗原表达与胃癌演变及预后的关系[J].新乡医学院学报,2004,21(02):000.
[11]贾文英,张合喜,马彦民.幽门螺杆菌感染与胃癌关系的Meta 分析[J].新乡医学院学报,2000,17(05):328.
[12]李　婷.血清胃蛋白酶原和幽门螺杆菌抗体检测在胃癌早期筛查中的应用价值[J].新乡医学院学报,2016,33(10):913.[doi:10.7683/xxyxyxb.2016.10.021]
　LI Ting.Value of serum pepsinogen and Helicobacter pylori antibody detection in screening early gastric carcinoma[J].Journal of Xinxiang Medical University,2016,33(8):913.[doi:10.7683/xxyxyxb.2016.10.021]

更新日期/Last Update: 2023-08-05